Berres Jennifer 4
4 · HCA Healthcare, Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Berres Jennifer
SVP & Chief Human Res. Officer
Transactions
- Tax Payment
Common Stock
2025-02-13$321.92/sh−407$131,021→ 24,945 total - Sale
Common Stock
2025-02-14$322.95/sh−4,155$1,341,878→ 20,790 total - Sale
Common Stock
2025-02-14$322.31/sh−5,378$1,733,362→ 15,412 total - Award
Common Stock
2025-02-13+1,588→ 25,352 total
Footnotes (3)
- [F1]On January 28, 2022, the reporting person was granted 3,060 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.71 to $323.28, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.70 to $322.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.